10 found
Order:
  1.  51
    Applying a propensity score‐based weighting model to interrupted time series data: improving causal inference in programme evaluation.Ariel Linden & John L. Adams - 2011 - Journal of Evaluation in Clinical Practice 17 (6):1231-1238.
  2.  27
    Using propensity score‐based weighting in the evaluation of health management programme effectiveness.Ariel Linden & John L. Adams - 2010 - Journal of Evaluation in Clinical Practice 16 (1):175-179.
  3.  69
    Strengthening the case for disease management effectiveness: un‐hiding the hidden bias.Ariel Linden, John L. Adams & Nancy Roberts - 2006 - Journal of Evaluation in Clinical Practice 12 (2):140-147.
  4.  89
    Evaluating disease management programme effectiveness: an introduction to instrumental variables.Ariel Linden & John L. Adams - 2006 - Journal of Evaluation in Clinical Practice 12 (2):148-154.
  5.  15
    Evaluating health management programmes over time: application of propensity score‐based weighting to longitudinal data.Ariel Linden & John L. Adams - 2010 - Journal of Evaluation in Clinical Practice 16 (1):180-185.
  6.  28
    Combining the regression discontinuity design and propensity score‐based weighting to improve causal inference in program evaluation.Ariel Linden & John L. Adams - 2012 - Journal of Evaluation in Clinical Practice 18 (2):317-325.
  7.  71
    Evaluating disease management programme effectiveness: an introduction to the regression discontinuity design.Ariel Linden, John L. Adams & Nancy Roberts - 2006 - Journal of Evaluation in Clinical Practice 12 (2):124-131.
  8.  35
    Improving participant selection in disease management programmes: insights gained from propensity score stratification.Ariel Linden & John L. Adams - 2008 - Journal of Evaluation in Clinical Practice 14 (5):914-918.
  9.  26
    Determining if disease management saves money: an introduction to meta‐analysis.Ariel Linden & John L. Adams - 2007 - Journal of Evaluation in Clinical Practice 13 (3):400-407.
  10.  18
    Patterns of osteoporosis treatment change and treatment discontinuation among commercial and Medicare Advantage Prescription Drug members in a national health plan.Yihua Xu, Hema N. Viswanathan, Melea A. Ward, Brad Clay, John L. Adams, Bradley S. Stolshek, Joel D. Kallich, Shari Fine & Kenneth G. Saag - 2013 - Journal of Evaluation in Clinical Practice 19 (1):50-59.